spacer
home > pmps > winter 2002 > the scope of validation for cleanroom disinfectants
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Scope of Validation for Cleanroom Disinfectants

The validation of disinfectants for use in controlled environments can be both lengthy and expensive. This article examines the scope of disinfectant validation and how to ensure a smooth and successful outcome. As a disinfectant manufacturer we have a unique perspective on validation as not only do we have an in-depth knowledge of disinfectants but we also operate cleanrooms to the same cGMP standards as pharmaceutical manufacturers. It also allows us to gain a broad range of experience across the many life science fields including the pharmaceutical, biotechnology and medical device industries where similar issues arise repeatedly. The message is simple: consider all aspects of new agents right from the start. This will produce quick and meaningful validation results, which subsequently leads to early implementation of new disinfectants and prompt responses to audits.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Andrew Davidson, Commercial Director of Shield Medicare Ltd
Andrew Davidson is the Commercial Director of Shield Medicare Ltd. His qualifications include a BSc (Hons) in Biological Sciences and a CIM Diploma in Marketing. He has been with Shield Medicare for six years, having been recruited to develop the contamination control business. Before this he worked in the pharmaceutical industry for 15 years in both sales and marketing and product development roles.

spacer
Andrew Davidson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement